Peter Wirth is Director of Forma Therapeutics Holdings, Inc.. Currently has a direct ownership of 0 shares of FMTX, which is worth approximately $0. The most recent transaction as insider was on Oct 14, 2022, when has been sold 134,915 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

PETER WIRTH Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 14 2022
SELL
Disposition due to a tender of shares in a change of control transaction
-
134,915 Reduced 100.0%
0 Common Stock
Jun 08 2022
BUY
Grant, award, or other acquisition
-
4,500 Added 3.23%
134,915 Common Stock
Jun 17 2021
BUY
Grant, award, or other acquisition
-
2,750 Added 2.07%
130,415 Common Stock

Also insider at

ZLAB
Zai Lab Ltd Healthcare
SYRS
Syros Pharmaceuticals, Inc. Healthcare
PW

Peter Wirth

Director
Cambridge, MA

Track Institutional and Insider Activities on FMTX

Follow Forma Therapeutics Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells FMTX shares.

Notify only if

Insider Trading

Get notified when an Forma Therapeutics Holdings, Inc. insider buys or sells FMTX shares.

Notify only if

News

Receive news related to Forma Therapeutics Holdings, Inc.

Track Activities on FMTX